J Hakim
Overview
Explore the profile of J Hakim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
219
Citations
1399
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Podany A, Leon-Cruz J, Hakim J, Supparatpinyo K, Omoz-Oarhe A, Langat D, et al.
J Antimicrob Chemother
. 2020 Nov;
76(3):718-721.
PMID: 33241266
Background: The use of rifamycin antibiotics for TB prevention carries a risk of detrimental drug-drug interactions with concomitantly used ART. Objectives: To evaluate the interaction of the antiretroviral drug nevirapine...
2.
Robertson K, Jiang H, Evans S, Marra C, Berzins B, Hakim J, et al.
J Neurovirol
. 2016 Jan;
22(4):472-8.
PMID: 26733457
Infrastructure for conducting neurological research in resource-limited settings (RLS) is limited. The lack of neurological and neuropsychological (NP) assessment and normative data needed for clinical interpretation impedes research and clinical...
3.
Abongomera G, Kiwuwa-Muyingo S, Revill P, Chiwaula L, Mabugu T, Phillips A, et al.
BMC Health Serv Res
. 2015 Nov;
15:527.
PMID: 26615587
Background: Decentralization of ART services scaled up significantly with the country wide roll out of option B plus in Uganda. Little work has been undertaken to examine population level access...
4.
Gapu P, Bwakura-Dangarembizi M, Kandawasvika G, Kao D, Bannerman C, Hakim J, et al.
S Afr Med J
. 2015 Aug;
105(5):384-8.
PMID: 26242684
Background: Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) remain significant causes of morbidity and mortality in resource-limited settings. In Zimbabwe ARF/RHD characteristics have not been systematically documented. Objectives:...
5.
Robertson K, Jiang H, Kumwenda J, Supparatpinyo K, Evans S, Campbell T, et al.
Clin Infect Dis
. 2012 Jun;
55(6):868-76.
PMID: 22661489
Background: AIDS Clinical Trials Group (ACTG) A5199 compared the neurological and neuropsychological (NP) effects of 3 antiretroviral regimens in participants infected with human immunodeficiency virus type 1 (HIV-1) in resource-limited...
6.
Kiwuwa-Muyingo S, Walker A, Oja H, Levin J, Miiro G, Katabira E, et al.
Trop Med Int Health
. 2012 Apr;
17(5):584-94.
PMID: 22463596
Objectives: To describe associations between different summaries of adherence in the first year on antiretroviral therapy (ART) and the subsequent risk of mortality, to identify patients at high risk because...
7.
Walker A, Ford D, Gilks C, Munderi P, Ssali F, Reid A, et al.
Lancet
. 2010 Mar;
375(9722):1278-86.
PMID: 20347483
Background: Co-trimoxazole prophylaxis can reduce mortality from untreated HIV infection in Africa; whether benefits occur alongside combination antiretroviral therapy (ART) is unclear. We estimated the effect of prophylaxis after ART...
8.
Babiker A, Gilks C, Munderi P, Kabuye G, Kasirye R, Zalwango E, et al.
Lancet
. 2009 Dec;
375(9709):123-31.
PMID: 20004464
Background: HIV antiretroviral therapy (ART) is often managed without routine laboratory monitoring in Africa; however, the effect of this approach is unknown. This trial investigated whether routine toxicity and efficacy...
9.
10.